Number needed to harm
Number Needed to Harm (NNH) is a statistical concept used in Epidemiology and Evidence-based medicine to quantify the number of patients that need to be treated with a particular intervention for one additional patient to experience a harmful event. It is the inverse of the Absolute risk reduction and is calculated from the Absolute risk increase (ARI) of a treatment or intervention.
Definition[edit]
The Number Needed to Harm is defined as the number of patients who need to be treated for one to be harmed by the treatment. It is calculated as the inverse of the Absolute Risk Increase, which is the difference in risk of a harmful event between two groups - usually a treatment group and a control group.
Calculation[edit]
The NNH is calculated using the formula:
NNH = 1 / ARI
Where ARI is the Absolute Risk Increase. The ARI is calculated as the difference in the risk of a harmful event between the treatment group and the control group.
Interpretation[edit]
The NNH is a useful measure for comparing the safety of different treatments or interventions. A lower NNH indicates a higher risk of harm, while a higher NNH indicates a lower risk of harm. It is important to note that the NNH is a population-level measure and does not predict the risk of harm for an individual patient.
Limitations[edit]
Like all statistical measures, the NNH has limitations. It assumes that the risk of harm is constant across all patients, which may not be the case in reality. It also does not take into account the severity of the harm, or the benefits of the treatment.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian